Cargando…
Modified heptapeptide from tau binds both tubulin and microtubules
BACKGROUND: Microtubules are the major cytoskeletal component in eukaryotes which are essential for a large spectrum of cellular activities. Monitoring the behavior of microtubules is helpful for a better understanding of the regulatory mechanism governing microtubule architecture and microtubule‐ba...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7529580/ https://www.ncbi.nlm.nih.gov/pubmed/32893987 http://dx.doi.org/10.1111/1759-7714.13643 |
_version_ | 1783589464058101760 |
---|---|
author | Li, Jingrui Li, Yuyang Liu, Min Xie, Songbo |
author_facet | Li, Jingrui Li, Yuyang Liu, Min Xie, Songbo |
author_sort | Li, Jingrui |
collection | PubMed |
description | BACKGROUND: Microtubules are the major cytoskeletal component in eukaryotes which are essential for a large spectrum of cellular activities. Monitoring the behavior of microtubules is helpful for a better understanding of the regulatory mechanism governing microtubule architecture and microtubule‐based activities. Here, we characterized the binding capability of a modified heptapeptide from tau to both tubulin and microtubules and sought to develop it as a fluorescent peptide for monitoring microtubules. METHODS: To deliver the fluorescent peptide into the cells, a cell‐penetrating peptide was conjugated to the modified heptapeptide from tau and synthesized. The affinity of the modified heptapeptide was determined by microscale thermophoresis. The microtubule labeling ability was determined by adding the peptide into the polymerized microtubule solutions or cultured HeLa cells.; RESULTS: Affinity determination revealed that the tau‐derived peptide specifically bound to tubulin. In addition, the peptide was able to label polymerized microtubules in solution, although no obvious microtubule filaments were observed clearly in living cells, probably due to the inadequate affinity. CONCLUSIONS: These results suggest that using a peptide‐based strategy for imaging microtubules might be plausible and attempts to improve its affinity is warranted in the future. |
format | Online Article Text |
id | pubmed-7529580 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley & Sons Australia, Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-75295802020-10-05 Modified heptapeptide from tau binds both tubulin and microtubules Li, Jingrui Li, Yuyang Liu, Min Xie, Songbo Thorac Cancer Brief Reports BACKGROUND: Microtubules are the major cytoskeletal component in eukaryotes which are essential for a large spectrum of cellular activities. Monitoring the behavior of microtubules is helpful for a better understanding of the regulatory mechanism governing microtubule architecture and microtubule‐based activities. Here, we characterized the binding capability of a modified heptapeptide from tau to both tubulin and microtubules and sought to develop it as a fluorescent peptide for monitoring microtubules. METHODS: To deliver the fluorescent peptide into the cells, a cell‐penetrating peptide was conjugated to the modified heptapeptide from tau and synthesized. The affinity of the modified heptapeptide was determined by microscale thermophoresis. The microtubule labeling ability was determined by adding the peptide into the polymerized microtubule solutions or cultured HeLa cells.; RESULTS: Affinity determination revealed that the tau‐derived peptide specifically bound to tubulin. In addition, the peptide was able to label polymerized microtubules in solution, although no obvious microtubule filaments were observed clearly in living cells, probably due to the inadequate affinity. CONCLUSIONS: These results suggest that using a peptide‐based strategy for imaging microtubules might be plausible and attempts to improve its affinity is warranted in the future. John Wiley & Sons Australia, Ltd 2020-09-07 2020-10 /pmc/articles/PMC7529580/ /pubmed/32893987 http://dx.doi.org/10.1111/1759-7714.13643 Text en © 2020 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Brief Reports Li, Jingrui Li, Yuyang Liu, Min Xie, Songbo Modified heptapeptide from tau binds both tubulin and microtubules |
title | Modified heptapeptide from tau binds both tubulin and microtubules |
title_full | Modified heptapeptide from tau binds both tubulin and microtubules |
title_fullStr | Modified heptapeptide from tau binds both tubulin and microtubules |
title_full_unstemmed | Modified heptapeptide from tau binds both tubulin and microtubules |
title_short | Modified heptapeptide from tau binds both tubulin and microtubules |
title_sort | modified heptapeptide from tau binds both tubulin and microtubules |
topic | Brief Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7529580/ https://www.ncbi.nlm.nih.gov/pubmed/32893987 http://dx.doi.org/10.1111/1759-7714.13643 |
work_keys_str_mv | AT lijingrui modifiedheptapeptidefromtaubindsbothtubulinandmicrotubules AT liyuyang modifiedheptapeptidefromtaubindsbothtubulinandmicrotubules AT liumin modifiedheptapeptidefromtaubindsbothtubulinandmicrotubules AT xiesongbo modifiedheptapeptidefromtaubindsbothtubulinandmicrotubules |